Author - Lisa Malette

Drug testing facilities should be screening for Kratom an opioid with potential for addiction and abuse. It is crucial to understand the physiological and psychological effects of Kratom, and how it is being used as an alternative to other opioids. In this webinar, Pat Pizzo, a renowned forensic toxicologist, discusses Kratom’s legal status, and the Drug Enforcement Agency (DEA), Food and Drug Administration (FDA), and advocacy groups’ position on its safety and uses. She’ll explore the history of Kratom, where [...]

Read more...

How the Digital Transformation in the Forensic Lab can Improve Efficiency and Drive Lab Success [Agilent]

In this webinar, we will look through the lens of gas chromatography as an example to explore how a digital transformation is evolving the analytical laboratory and driving better outcomes. We will discuss how this digital transformation is reducing unplanned downtime and improving lab efficiency. Smart connected instruments help operators deliver better analytical results. And when necessary, smart instruments can guide users through troubleshooting and maintenance routines in a step-by-step fashion to complete these tasks most efficiently. Directed at operators and [...]

Read more...

Is it Hemp? An Analytical Strategy To Make Sure It Is [Agilent]

Hemp must be legally differentiated from marijuana. Herein, we discuss an orthogonal analytical strategy for screening and putative quantification of tetrahydrocannabinol in hemp, followed by speciation and quantitative confirmation. The Agriculture Improvement Act, also known as the Farm Bill was signed into law in December 2018. A major provision in the law legalizes hemp as an industrial crop. The United States Federal Register defines industrial hemp as any part or derivative (including seeds) of the plant Cannabis sativa L. with [...]

Read more...